FDA to delay decision on Eli Lilly Alzheimer's drug for second time
Go back to FDA to delay decision on Eli Lilly Alzheimer's drug for second time| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 220.83 -3.68 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.51 | 52 Week High | $333.65 | |||
| Open | $221.15 | 52 Week Low | $223.02 | |||
| Day High | $223.82 | P/E | 28.28 | |||
| Day Low | $219.82 | EPS | $7.81 | |||
| Volume | 465,108 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1149.36 -10.24 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1159.60 | 52 Week High | $88.16 | |||
| Open | $1150.61 | 52 Week Low | $67.88 | |||
| Day High | $1158.44 | P/E | 266.06 | |||
| Day Low | $1138.31 | EPS | $4.32 | |||
| Volume | 2,220,270 | |||||
